Testicular Cancer

Why Yale Urology

At Yale Urology, we understand the physical and emotional toll any form of cancer takes on patients and their families which leaves you and your loved ones with many questions about the journey ahead. Our team members are dedicated to providing the compassionate care, support, and information you need to move forward confidently with your treatment process.  

We are committed to offering our patients with early- and late-stage testicular cancer the most advanced diagnostic technologies and treatment strategies available. With the appropriate treatment, even metastatic testicular cancer can have an excellent outcome, but it is vital to be treated by experts in a multidisciplinary setting.

Innovative Methods

Yale Urology offers a full slate of advanced medical and surgical procedures to address testicular cancer. Surgical removal of a malignant testicle is the most common treatment, with no impact on sexual performance or the ability to father children. Radiation or chemotherapy may be needed in some cases. 

About Testicular Cancer

Testicular cancer is a disease in which cells in the male testes (the sperm-producing glands inside the scrotum) become malignant. Testicular cancer is rare – only about 8,000 new cases are diagnosed each year – but it is also the most common cancer among 15- to 34-year-old men in the United States. 

Testicular cancer is highly treatable, with more than 95 percent of patients cured. Regular self-examinations can help identify problems early on, increasing the likelihood of successful treatment.

Additional information about testicular cancer: